Clinical development of Modified Vaccinia virus Ankara vaccines.
The smallpox vaccine Vaccinia was successfully used to eradicate smallpox, but although very effective, it was a very reactogenic vaccine and responsible for the deaths of one or two people per million vaccinated. Modified Vaccinia virus Ankara (MVA) is a replication-deficient and attenuated derivat...
Հիմնական հեղինակ: | Gilbert, S |
---|---|
Ձևաչափ: | Journal article |
Լեզու: | English |
Հրապարակվել է: |
2013
|
Նմանատիպ նյութեր
-
Clinical development of Modified Vaccinia virus Ankara vaccines
: Gilbert, S
Հրապարակվել է: (2013) -
Development of Modified Vaccinia Virus Ankara-Based Vaccines: Advantages and Applications
: Olga Vladimirovna Orlova, և այլն
Հրապարակվել է: (2022-09-01) -
Ty virus-like particles, DNA vaccines and Modified Vaccinia Virus Ankara; comparisons and combinations.
: Gilbert, S, և այլն
Հրապարակվել է: (1999) -
Safety and immunogenicity of DNA/modified vaccinia virus ankara malaria vaccination in African adults.
: Moorthy, V, և այլն
Հրապարակվել է: (2003) -
Modified Vaccinia virus Ankara-based vaccines in the era of personalized immunotherapy of cancer
: Kaïdre Bendjama, և այլն
Հրապարակվել է: (2017-09-01)